Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| May 20 | VCYT | Veracyte, INC. | SSELL◷ | 10,000 | $44.01 | $440.1K | -16.0% | Open the original filing on SEC.gov |
| May 5 | FATE | Fate Therapeutics INC | MEXER◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| May 5 | FATE | Fate Therapeutics INC | MEXER | 25,000 | $1.69 | $42.3K | +220.6% | Open the original filing on SEC.gov |
| Oct 1, 2025 | VCYT | Veracyte, INC. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 1, 2025 | VCYT | Veracyte, INC. | SSELL◷ | 21,473 | $35.08 | $753.2K | -25.6% | Open the original filing on SEC.gov |
| Oct 1, 2025 | VCYT | Veracyte, INC. | MEXER◷ | 10,000 | $7.94 | $79.4K | +13.5% | Open the original filing on SEC.gov |
| Jun 18, 2025 | VCYT | Veracyte, INC. | AGRANT | 9,321 | — | — | +14.4% | Open the original filing on SEC.gov |
| May 29, 2025 | FATE | Fate Therapeutics INC | AGRANT◆ | 55,000 | — | — | — | Open the original filing on SEC.gov |
| May 21, 2025 | ILMN | Illumina, INC. | AGRANT | 3,780 | — | — | +20.6% | Open the original filing on SEC.gov |